The stock of Humana Inc. (NYSE:HUM) last traded at $430.14, down -2.46% from the previous session.
Data from the available sources indicates that Humana Inc. (NYSE:HUM) is covered by 25 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $640.00 and a low of $524.00, we find $591.00. Given the previous closing price of $440.99, this indicates a potential upside of 34.02 percent. HUM stock price is now -13.41% away from the 50-day moving average and -15.01% away from the 200-day moving average. The market capitalization of the company currently stands at $55.10B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
In total, 7 analysts have assigned it a hold rating, and 17 have given it a buy rating. Brokers who have rated the stock have averaged $589.09 as their price target over the next twelve months.
With the price target reduced from $576 to $540, JP Morgan Downgraded its rating from Overweight to Neutral for Humana Inc. (NYSE: HUM).
In other news, Diamond Susan M, Chief Financial Officer sold 4,156 shares of the company’s stock on May 04. The stock was sold for $2,187,226 at an average price of $526.28. Upon completion of the transaction, the Chief Financial Officer now directly owns 3,931 shares in the company, valued at $1.69 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 27, President & CEO BROUSSARD BRUCE D sold 17,575 shares of the business’s stock. A total of $8,890,233 was realized by selling the stock at an average price of $505.85. This leaves the insider owning 70,040 shares of the company worth $30.13 million. Insiders disposed of 198,234 shares of company stock worth roughly $85.27 million over the past 1 year. A total of 0.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in HUM stock. A new stake in Humana Inc. shares was purchased by OFI INVEST ASSET MANAGEMENT during the first quarter worth $91,461,000. POINT72 ASSET MANAGEMENT, L.P. invested $81,330,000 in shares of HUM during the first quarter. In the first quarter, DISCOVERY CAPITAL MANAGEMENT, LLC / CT acquired a new stake in Humana Inc. valued at approximately $61,635,000. CEREDEX VALUE ADVISORS LLC acquired a new stake in HUM for approximately $55,929,000. JUNTO CAPITAL MANAGEMENT LP purchased a new stake in HUM valued at around $38,152,000 in the second quarter. In total, there are 1,518 active investors with 96.10% ownership of the company’s stock.
With an opening price of $436.68 on Friday morning, Humana Inc. (NYSE: HUM) set off the trading day. During the past 12 months, Humana Inc. has had a low of $435.00 and a high of $571.30. According to the stock market information, the enterprise value for the company is $52.02B, which is based on a 17.48 price-to-earnings ratio, a 1.29 price-to-earnings-growth ratio, and a beta of 0.67. The fifty day moving average price for HUM is $495.32 and a two-hundred day moving average price translates $505.75 for the stock.
The latest earnings results from Humana Inc. (NYSE: HUM) was released for Mar, 2023. According to the Healthcare Plans Company, earnings per share came in at $9.38, beating analysts’ expectations of $9.27 by 0.11. This compares to $7.30 EPS in the same period last year. The net profit margin was 3.30% and return on equity was 19.60% for HUM. The company reported revenue of $26.74 billion for the quarter, compared to $23.97 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 11.56 percent. For the current quarter, analysts expect HUM to generate $26.18B in revenue.
Moreover, the firm recently paid out its quarterly dividend on 07/28/2023. Investors who held shares on 06/30/2023 were paid a $0.885 dividend. On an annualized basis, this represents a $3.54 dividend and a 0.82% percent yield. There was an ex-dividend date of 06/29/2023 for this dividend. In terms of dividend payout ratio, HUM is presently at 13.10%.
Humana Inc.(HUM) Company Profile
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of PBM business. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
